770-807-8445   |   cs@irrisept.com
iStock_000036273582_Medium

Investors

Irrimax Corporation is a wholly owned subsidiary of Innovation Technologies, Inc. Innovation Technologies holds the rights to US and worldwide patents that provide broad protection for the use of low concentration CHG (less than 1%) technology. Irrimax Corporation develops, manufactures and markets Irrisept Antimicrobial Wound Lavage, a single-use, manual, self-contained irrigation device comprised of (1) 450mL bottle of 0.05% Chlorhexidine Gluconate (CHG) in 99.95% Sterile Water for Irrigation, United States Pharmacopeia (USP).

If you are a current investor and need to contact the company, please email: investorinfo@irrimax.com or call +1 770.807.3355

Share:

Print Friendly, PDF & Email
request a sample

About Irrisept

Irrisept is jet lavage containing low concentration Chlorhexidine Gluconate (CHG)…click here and learn more about our flagship product.

FAQs

For answers to important questions, ordering information and more...click here to review our FAQs.
IRRISEPT-antimicrobial-wound-lavage-logoFINAL-WHITE

© 2022 Irrimax Corporation. All Rights Reserved.
Irrimax®, Irrisept®, Irririnse®, Irriprobe® and Splatterguard® (all regardless of letter case) are registered trademarks of Innovation Technologies, Inc., parent company of Irrimax Corporation.